Navigation Links
New Topical Painkiller Relieves Severe Pain in Minutes
Date:4/13/2009

ENCINO, Calif., April 13 /PRNewswire/ bluMjk (pronounced "Blue Magic"), a new over-the-counter topical painkiller, uses patent pending skin and nerve penetrating technology to relieve the majority of moderate to severe pain experienced by most pain sufferers. Within minutes of a topical application, bluMjk restores pain nerve fibers to their natural resting state, which eliminates the sensation of pain. R & S Research developed this new penetrating technology to quickly and safely deliver the active ingredient, salicylate, deep into the skin and target nerve cells without any side- effects.

Salicylate has historically been an effective oral pain reliever acting as a Non-Steroidal Anti-Inflammatory Drug, with the same mode of action as aspirin or ibuprofen. Topically, applied bluMjk works much faster and much more powerfully to relieve moderate to severe pain in a wide variety of pain conditions.

The unique combination of all natural ingredients which comprise the carrier system of this new formulation bring the active ingredient, salicylate, through the layers of the skin and then through the cell membrane of the nerves that transmit the sensation of pain to the brain. Because of the speed with which bluMjk works the R & S Research team concluded the effect of bluMjk on these pain nerves is to shut off their output and restore them to a resting state. Because bluMjk is not an anesthetic it has no effect on any other nerves, and sensations of touch, pressure, hot, cold, etc are unaffected by this medication. Since the effect of bluMjk takes place where the pain originates there is no effect on the brain and therefore no chance of habituation or addiction. bluMjk is as powerful as a narcotic and as safe as aspirin.

bluMjk has been used in a large variety of clinical pain syndromes effectively, including tension and migraine headaches, both osteo and rheumatoid arthritis, various ner
'/>"/>

SOURCE R & S Research
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Topical Dermatological Product Development in the USA Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USA
2. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
3. Topical Spray Helped Men With Premature Ejaculation
4. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
5. Global Warming Expected to Spike Pollen and Spring Allergies - New Drug-Free Topical Gels Boost Hope for Allergy Sufferers
6. Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
7. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
8. NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009
9. American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies
10. High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis
11. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
...reports 21% sequential growth in domestic handpiec...is,Corporation (Pink Sheets: CGCP), a leading deve... angina-relieving procedures, today reported,finan...first quarter sales of $3,370,000. During the firs...
...Simmons Kicks-Off National Sampling Initiative wit... NYC,s Penn Station, LAKEVILLE-MIDDLEBORO, Mass.,...to energize the country and lift people from,Ameri...eople need an extra boost to keep them on the go. ...
..., May 15 MS -- "Eat your vegetables!" is a plea,o...that many young children,don,t seem to like vegeta...,fact, developed prenatally," says Jane Kostelc, e...s that unborn babies may detect,taste differences ...
...g to a new study from the University of Minnesota,...ced skin cancer may have been identified. The rese...cer in response to sun exposure is in receptor mol...earch appears in the May 15 issue of Cancer Resear...
... FL, May 19, 2008 Losing weight may help resolve ...search presented today at the 103rd Annual Scienti... (AUA). Morbid obesity can cause sexual dysfunctio... sexual function was normalized in some men who un...
... FL, May 21, 2008Men with greater access to prosta...comes from the disease, a new study shows. Urologi...eased numbers of screening programs and decreased ... Surveillance System of the Centers for Disease Co...
Other Medicine News:Health News:Cardiogenesis Reports First Quarter 2008 Results 2Health News:Cardiogenesis Reports First Quarter 2008 Results 3Health News:Cardiogenesis Reports First Quarter 2008 Results 4Health News:Cardiogenesis Reports First Quarter 2008 Results 5Health News:Cardiogenesis Reports First Quarter 2008 Results 6Health News:Video: Ocean Spray Revitalizes Americans Naturally With Free Fuel for Their Bodies 2Health News:Eat Your Vegetables - That Means You, Parents! 2Health News:U of Minnesota researcher discovers the starting point of sun-induced skin cancer 2
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Company Reverses Course 3A The Billboard Roy Blunt Doesnt Want You To See Will Go Up After All 54571 1Company Reverses Course 3A The Billboard Roy Blunt Doesnt Want You To See Will Go Up After All 54571 2AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 1AMDL Inc Files Notification of Late Filing for Form 10 Q 54569 2Statewide program to improve emergency care for children 54567 1Statewide program to improve emergency care for children 54567 2
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)
Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial
Other Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
... The integration of Trabecular Metal ... implant design results in a fusion ... only meets surgeon demands for initial ... a wide variety of shell and ...
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: